Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites

Carcinogenesis

Volumn 20, Issue 10, 1999, Pages 1885-1891

  Melendez Colon, Victor J ^a,b   Luch, Andreas ^c   Seidel, Albrecht ^d   Baird, William M ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME P450; DIMETHYLBENZ[A]ANTHRACENE; EPOXIDE; PEROXIDASE; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON; PYRENE DERIVATIVE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; COVALENT BOND; DNA ADDUCT; DNA DAMAGE; DRUG DNA BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MOUSE; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

ANIMALS; CARBON-OXYGEN LYASES; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DEOXYRIBONUCLEASE IV (PHAGE T4-INDUCED); DNA; DNA ADDUCTS; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; HUMANS; MICE; MICE, INBRED SENCAR; POLYCYCLIC COMPOUNDS;

EID: 0032832051     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.10.1885     Document Type: Article

References (60)

1. Cavalieri, E.L., Higginbotham, S., RamaKrishna, N.V.S., Devanesan, P.D., Todorovic, R., Rogan, E.G. and Salmasi, S. (1991) Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis, 12, 1939-1944.
2. Grimmer, G. (1983) Environmental Carcinogens: Polycyclic Aromatic Hydrocarbons. CRC Press, Boca Raton, FL.
3. Harvey, R.G. (1991) Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity. Cambridge University Press, Cambridge, UK.
4. LaVoie, E.J., He, Z.-M., Meegalla, R.L. and Weyand, E.H. (1993) Exceptional tumor-initiating activity of 4-fluorobenzo[j]fluoranthene on mouse skin: comparison with benzo[j]fluoranthene, 10-fluoro-benzo[j]fluoranthene, benzo[a]pyrene, dibenzo[a,l]pyrene and 7,12-dimethylbenz[a]anthracene. Cancer Lett., 70, 7-14.
5. DiGiovanni, J. (1992) Multistage carcinogenesis in mouse skin. Pharmac. Ther., 54, 63-128.
6. Higginbotham, S., RamaKrishna, N.V.S., Johansson, S.L., Rogan, E.G. and Cavalieri, E.L. (1993) Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis, 14, 875-878.
7. DuBowski, A., Johnston, D.A., Rupp, T., Beltran, L., Conti, C.J. and DiGiovanni, J. (1998) Papillomas at high risk for malignant progression arising both early and late during two-stage carcinogenesis in SENCAR mice. Carcinogenesis, 19, 1141-1147.
8. Schmidt, R. and Hecker, E. (1989) Biological assays for irritant, tumor-initiating and tumor-promoting activities II. Standardized initiation/ promotion protocol and semiquantitative estimation of promoting (or initiating) potencies in skin of NMRI mice. J. Cancer Res. Clin. Oncol., 115, 516-524.
9. Cavalieri, E.L., Rogan, E.G., Higginbotham, S., Cremonesi, P. and Salmasi, S. (1989) Tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a]pyrenes: the very potent environmental carcinogen dibenzo[a,l]pyrene. J. Cancer Res. Clin. Oncol., 115, 67-72.
10. Brookes, P. and Lawley, P.D. (1964) Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature, 202, 781-784.
11. Sims, P., Grover, P.L., Swaisland, A., Pal, K. and Hewer, A. (1974) Metabolic activation of benzo[a]pyrene proceeds by a diol-epoxide. Nature, 252, 326-328.
12. Kooreda, M., Moore, P.D., Wislocki, P.G., Levin, W., Conney, A.H., Yagi, H. and Jerina, D.M. (1978) Binding of benzo[a]pyrene 7,8-diol 9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity. Science, 199, 778-781.
13. Meehan, T. and Calvin, M. (1979) Double-stranded DNA stereoselectively binds benzo[a]pyrene diol epoxides. Nature, 277, 410-412.
14. Moschel, R.C., Baird, W.M. and Dipple, A. (1977) Metabolic activation of the carcinogen 7,12-dimethylbenz[a]anthracene for DNA binding. Biochem. Biophys. Res. Commun., 76, 1092-1098.
15. Bigger, C.A.H., Sawicki, J.T., Blake, D.M., Raymond, L.G. and Dipple, A. (1983) Products of binding of DMBA to DNA in mouse skin. Cancer Res., 43, 5647-5651.
16. Rabinowitz, J.R., Little, S.B. and Lewis-Bevan, L. (1996) The effect of crowding in the bay/fjord region on the structure and reactivities of polycyclic aromatic hydrocarbons and their metabolites: quantum mechanical studies. Polycyclic Aromat. Comp., 11, 237-244.
17. Dipple, A., Pigott, M., Moschel, R.C. and Costantino, N. (1983) Evidence that binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Cancer Res., 43, 4132-4135.
18. Cheng, S.C., Prakash, A.S., Pigott, M.A., Hilton, B.D., Roman, J.M., Lee, H., Harvey, R.G. and Dipple, A. (1988) Characterization of 7,12-dimethylbenz[a]anthracene-adenine nucleoside adducts. Chem. Res. Toxicol., 1, 216-221.
19. Katz, A.K., Carrell, H.L. and Glusker, J.P. (1998) Dibenzo[a,l]pyrene (dibenzo[def,p]chrysene): fjord-region distortions. Carcinogenesis, 19, 1641-1648.
20. Ralston, S.L., Lau, H.H.S., Seidel, A., Luch, A., Platt, K.L. and Baird, W.M. (1994) The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures. Cancer Res., 54, 887-890.
21. Ralston, S.L., Lau, H.H.S., Seidel, A., Luch, A., Platt, K.L. and Baird, W.M. (1994) Identification of dibenzo[a,l]pyrene-DNA adducts formed in cells in culture and in mouse skin. Polycyclic Aromat. Comp., 6, 199-206.
22. Ralston, S.L., Seidel, A., Luch, A., Platt, K.L. and Baird, W.M. (1995) Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti(11R,12S,13S,14R)-and ( + )-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis, 16, 2899-2907.
23. Guengerich, F.P. and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4, 391-407.
24. Guengerich, F.P. (1992) Metabolic activation of carcinogens. Pharmacol. Ther., 54, 17-61.
25. Hall, M. and Grover, P.L. (1990) Polycyclic aromatic hydrocarbons: metabolism, activation and tumour initiation. In Cooper, C.S. and Grover, P.L. (eds.) Chemical Carcinogenesis and Mutagenesis, Vol. I. Springer-Verlag, Heidelberg, pp. 327-372.
26. Szeliga, J. and Dipple, A. (1998) DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol. 11, 1-11.
27. Cavalieri, E.L. and Rogan, E.G. (1984) Role of radical cations in aromatic hydrocarbon carcinogenesis. Environ. Health Perspect., 64, 69-84.
28. Cavalieri, E.L. and Rogan, E.G. (1995) Central role of radical cations in metabolic acitivation of polycyclic aromatic hydrocarbons. Xenobiotica, 25, 677-688.
29. Li, K.-M., Todorovic, R., Rogan, E.G., Cavalieri, E.L., Ariese, F., Suh, M., Jankowiak, R. and Small, G.J. (1995) Identification and quantitation of dibenzo[a,l]pyrene-DNA adducts formed by rat liver microsomes in vitro: preponderance of depurination adducts. Biochemistry, 34, 8043-8049.
30. Cavalieri, E.L. and Rogan, E.G. (1996) The primary role of apurinic sites in tumor initiation. Polycyclic Aromat. Comp., 10, 251-258.
31. Chakravarti, D., Pelling, J.C., Cavalieri, E.L. and Rogan, E.G. (1995) Relating aromatic hydrocarbon-induced DNA adducts and c-Ha-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc. Natl Acad. Sci. USA, 92, 10422-10426.
32. Melendez-Colon, V.J., Smith, C.A., Seidel, A., Luch, A., Platt, K.L. and Baird, W.M. (1997) Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides. Proc. Natl Acad. Sci. USA, 94, 13542-13547.
33. Melendez-Colon, V.J., Luch, A., Seidel, A. and Baird, W.M. (1999) Comparison of cytochrome P450 and peroxidase dependent metabolic activation of the potent carcinogen dibenzo[a,l]pyrene in human cell lines: formation of stable DNA adducts and absence of a detectable increase in apurinic sites. Cancer Res., 59, 1412-1416.
34. Nakamura, J., Walker, V.E., Upton, P.B., Chiang, S., Kow, Y.W. and Swenberg, J. (1998) Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res., 58, 222-225.
35. Kubo, K., Ide, H., Wallace, S.S. and Kow, Y.W. (1992) A novel, sensitive, and specific assay for abasic sites, the most commonly produced DNA lesion. Biochemistry, 31, 3703-3708.
36. Einolf, H.J., Amin, S., Yagi, H., Jerina, D.M. and Baird, W.M. (1996) Benzo[c]phenanthrene is activated to DNA-binding diol epoxides in the human mammary carcinoma cell line MCF-7 but only limited activation occurs in mouse skin. Carcinogenesis, 17, 2237-2244.
37. Lau, H.H.S., Coffing, S.L., Lee, H., Harvey, R.G. and Baird, W.M. (1995) Stereoselectivity of activation of 7,12-dimethylbenz[a]anthracene-3,4-dihydrodiol to the anti-diol epoxide metabolite in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay. Chem. Res. Toxicol., 8, 970-978.
38. Rho, O., Bol, D.K., You, J., Beltran, L., Rupp, T. and DiGiovanni, J. (1996) Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin. Mol. Carcinog., 17, 62-69.
39. 35S]phosphorothioate labeling and HPLC. Carcinogenesis, 12, 885-893.
40. Lau, H.H.S. and Baird, W.M. (1994) Separation and characterization of post-labeled DNA adducts of stereoisomers of benzo[a]pyrene-7,8-diol-9,10-epoxide by immobilized boronate chromatography and HPLC analysis. Carcinogenesis, 15, 907-915.
41. Baird, W.M. and Ralston, S.L. (1997) Carcinogenic polycyclic aromatic hydrocarbons. In Sipes, I.G., McQueen, C.A. and Gandolfi, A.J. (eds) Comprehensive Toxicology, Vol. 12. Cambridge University Press, Cambridge, UK, pp. 171-200.
42. Gill, H.S., Kole, P.L., Wiley, J.C., Li, K.-M., Higginbotham, S., Rogan, E.G. and Cavalieri, E.L. (1994) Synthesis and tumor-initiating activity in mouse skin of dibenzo[a,l]pyrene syn-and anti-fjord-region diolepoxides. Carcinogenesis, 15, 2455-2460.
43. Casale, G.P., Higginbotham, S., Johansson, S.L., Rogan, E.G. and Cavalieri, E.L. (1997) Inflammatory response of mouse skin exposed to the very potent carcinogen dibenzo[a,l]pyrene: a model for tumor promotion. Fund. Appl. Toxicol., 36, 71-78.
44. Li, K.-M., Todorovic, R., Cavalieri, E.L., Rogan, E.G., Jankowiak, R. and Small, G. (1997) Depurinating DNA adducts detected in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P), DB[a,l]P-11,12-dihydrodiol, (±)-anti-DB[a,l]P diol epoxide (DE) or (±)-syn-DB[a,l]PDE. Proc. Am. Assoc. Cancer Res., 38, 127.
45. Chakravarti, D., Mailander, P., Franzen, J., Higginbotham, S., Cavalieri, E.L. and Rogan, E.G. (1998) Detection of dibenzo[a,l]pyrene-induced H-ras codon 61 mutant genes in preneoplastic SENCAR mouse skin using a new PCR-RFLP method. Oncogene, 16, 3203-3210.
46. Devanesan, P.D., RamaKrishna, N.V.S., Padmavathi, N.S., Higginbotham, S., Rogan, E.G., Cavalieri, E.L., Marsch, G.A., Jankowiak, R. and Small, G.J. (1993) Identification and quantitation of 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse skin. Chem. Res. Toxicol., 6, 364-371.
47. Rogan, E.G., Devanesan, P.D., RamaKrishna, N.V.S., Higginbotham, S., Padmavathi, N.S., Chapman, K., Cavalieri, E.L., Jeong, H., Jankowiak, R. and Small, G.J. (1993) Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol., 6, 356-363.
48. Todorovic, R., Ariese, F., Devanesan, P.D., Jankowiak, R., Small, G.J., Rogan, E.G. and Cavalieri, E.L. (1997) Determination of benzo[a]pyrene-and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands. Chem. Res. Toxicol., 10, 941-947.
49. Todorovic, R., Li, K.-M., Rogan, E.G. and Cavalieri, E.L. (1996) Identification and quantitation of DNA adducts of benzo[a]pyrene (BP), 7,12-dimethylbenz[a]anthracene (DMBA) and dibenzo[a,l]pyrene (DB[a,l]P) formed in rat mammary glands. Proc. Am. Assoc. Cancer Res., 37, 119.
50. Wood, R.D. (1996) DNA repair in eukaryotes. Annu. Rev. Biochem., 65, 135-167.
51. Loeb, L.A. (1989) Endogenous carcinogenesis: molecular oncology into the twenty-first century - Presidential address. Cancer Res., 49, 5489-5496.
52. Braithwaite, E., Wu, X. and Wang, Z. (1998) Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro. Carcinogenesis, 19, 1239-1246.
53. Braithwaite, E., Wu, X. and Wang, Z. (1999) Repair of DNA lesions: mechanisms and relative repair efficiencies. Mutat. Res., 424, 207-219.
54. Friedberg, E.C., Walker, G.C. and Siede, W. (1995) DNA Repair and Mutagenesis. American Society for Microbiology Press, Washington, DC.
55. Cooper, C.S. (1990) The role of oncogene activation in chemical carcinogenesis. In Cooper, C.S. and Grover, P.L. (eds) Chemical Carcinogenesis and Mutagenesis, Vol. II. Springer-Verlag, New York, NY, pp. 319-352.
56. Denissenko, M.F., Pao, A., Tang, M.-S. and Pfeifer, G.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
57. Prahalad, A.K., Ross, J.A., Nelson, G.B., Roop, B.C., King, L.C., Nesnow, S. and Mass, M.J. (1997) Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis, 18, 1955-1963.
58. Colapietro, A.M., Goodell, A.L. and Smart, R.C. (1993) Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels. Carcinogenesis, 14, 2289-2295.
59. Brown, K., Buchmann, A. and Balmain, A. (1990) Carcinogen-induced mutations in the mouse skin c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl Acad. Sci. USA, 87, 538-542.
60. Quintanilla, M., Brown, K., Ramsden, M. and Balmain, A. (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature, 322, 78-80.